Trial
NCT01208233
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Ischemic Stroke
Intervention
PF-03049423
Why stopped
See termination reason in detailed description.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-19